CB-Smart: A Cloud-Based Machine Learning Platform for Screening Cannabinoid Receptor Ligands
ACS Omega · 10.11.2026 · 11 (44) · 68127-68143
DOI: 10.1021/acsomega.6c00303 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 27.10.2026. Verfasst von Sahil Kabir und 2 weiteren Autor:innen. Beteiligte Einrichtung: ArGan'sLab, Department of Chemistry and Biochemistry, Faculty of Science, Wilfrid Laurier University, Waterloo, Ontario N2L 3C5, Canada. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada, Alliance de recherche num?rique du Canada.
Abstract (Originalsprache)
Cannabinoid receptors CB1 and CB2 are class A G protein-coupled receptors (GPCRs) implicated in pain modulation, neuroinflammation, immune regulation, and metabolic processes, making them important therapeutic targets. Conventional structure-based virtual screening for cannabinoid ligands remains computationally intensive and limited in throughput. To overcome this challenge, this work presents CB-Smart, a cloud-enabled machine learning (ML) platform to predict binding of ligands and their relative binding affinity to CB1 and CB2. Using curated experimentally validated ligands and GPCR decoy datasets, we trained five supervised ML algorithms, XGBoost, Support Vector Machines (SVM), Random Forests, Multi-Layer Perceptron (MLP), and k-Nearest Neighbors (KNN). Three featurization strategies, ECFP molecular fingerprints, RDKit 210 molecular descriptors, and Lipinski descriptors, were systematically evaluated. Models built on ECFP fingerprint features, particularly XGBoost, SVM, and MLP, demonstrated the highest performance on both reserved test datasets and an external dataset. A hard-voting ensemble integrating the top three classifiers further enhanced predictive performance. Further, SHAP-based interpretability analysis highlighted key structural and physicochemical drivers of cannabinoid receptor binding, offering insights into ligand-receptor interactions and structure-activity relationships. Finally, we integrated classification and regression models into an interactive, user-friendly cloud platform, enabling broad accessibility for virtual screening, medicinal chemistry optimization and early-stage drug discovery efforts targeting cannabinoid receptors.
Autor:innen und Institutionen
- ArGan'sLab, Department of Chemistry and Biochemistry, Faculty of Science, Wilfrid Laurier University, Waterloo, Ontario N2L 3C5, Canada.
- ArGan'sLab, School of Pharmacy, Faculty of Science, University of Waterloo, Waterloo, Ontario N2G 1C5, Canada.
ORCID-Profile: Aravindhan Ganesan
Förderung
- Natural Sciences and Engineering Research Council of Canada
- Alliance de recherche num?rique du Canada
Zitieren
APA
Kabir, S., El-Samman, A. M., & Ganesan, A. (2026). CB-Smart: A Cloud-Based Machine Learning Platform for Screening Cannabinoid Receptor Ligands. ACS Omega, 11(44), 68127-68143. https://doi.org/10.1021/acsomega.6c00303
Vancouver
Kabir S, El-Samman AM, Ganesan A. CB-Smart: A Cloud-Based Machine Learning Platform for Screening Cannabinoid Receptor Ligands. ACS Omega. 2026;11(44):68127-68143. doi:10.1021/acsomega.6c00303
BibTeX
@article{Kabir2026,
author = {Kabir, Sahil and El-Samman, Amer Marwan and Ganesan, Aravindhan},
title = {CB-Smart: A Cloud-Based Machine Learning Platform for Screening Cannabinoid Receptor Ligands},
journal = {ACS Omega},
year = {2026},
volume = {11},
number = {44},
pages = {68127--68143},
doi = {10.1021/acsomega.6c00303}
}
EUVIMED